炎症小体抑制剂。
Inflammasome Inhibitors.
机构信息
Department of Drug Science and Technology, University of Turin, Via Giuria 9, 10125 Torino, Italy.
出版信息
Molecules. 2021 Nov 16;26(22):6912. doi: 10.3390/molecules26226912.
Abstract
In recent years, the interplay between the activation of the immune system, the development of chronic inflammation and the onset and progression of many different diseases has been studied extensively [...].
摘要
近年来，免疫系统的激活、慢性炎症的发展以及许多不同疾病的发生和进展之间的相互作用已经得到了广泛的研究[...]。
相似文献
1
Inflammasome Inhibitors.炎症小体抑制剂。
Molecules. 2021 Nov 16;26(22):6912. doi: 10.3390/molecules26226912.
2
Current status of terpenoids as inflammasome inhibitors.萜类化合物作为炎症小体抑制剂的研究现状。
Biochem Pharmacol. 2020 Feb;172:113739. doi: 10.1016/j.bcp.2019.113739. Epub 2019 Nov 28.
3
Inflammasome inhibitors: promising therapeutic approaches against cancer.炎症小体抑制剂：癌症治疗的新途径。
J Hematol Oncol. 2019 Jun 26;12(1):64. doi: 10.1186/s13045-019-0755-0.
4
Inhibiting the Inflammasome: A Chemical Perspective.抑制炎症小体：化学视角。
J Med Chem. 2016 Mar 10;59(5):1691-710. doi: 10.1021/acs.jmedchem.5b01091. Epub 2015 Oct 12.
5
Therapeutic regulation of the NLRP3 inflammasome in chronic inflammatory diseases.NLRP3 炎性小体在慢性炎症性疾病中的治疗调控。
Arch Pharm Res. 2021 Jan;44(1):16-35. doi: 10.1007/s12272-021-01307-9. Epub 2021 Feb 3.
6
Contribution of inflammasome complex in inflammatory-related eye disorders and its implications for anti-inflammasome therapy.炎症小体复合物在炎症相关性眼部疾病中的作用及其在抗炎症小体治疗中的意义。
Immunopharmacol Immunotoxicol. 2020 Oct;42(5):400-407. doi: 10.1080/08923973.2020.1808986. Epub 2020 Aug 29.
7
Recent Progress on the Discovery of NLRP3 Inhibitors and their Therapeutic Potential.NLRP3 抑制剂的发现及治疗潜力的最新进展。
Curr Med Chem. 2021;28(3):569-582. doi: 10.2174/0929867327666200123093544.
8
Current status of inflammasome blockers as anti-inflammatory drugs.炎症小体抑制剂作为抗炎药物的研究现状。
Expert Opin Investig Drugs. 2012 Jul;21(7):995-1007. doi: 10.1517/13543784.2012.690032. Epub 2012 May 22.
9
The NLRP3 Inflammasome as a Pharmacological Target.NLRP3 炎性小体作为药物靶点。
J Cardiovasc Pharmacol. 2019 Oct;74(4):285-296. doi: 10.1097/FJC.0000000000000718.
10
The strategies of targeting the NLRP3 inflammasome to treat inflammatory diseases.靶向 NLRP3 炎性小体治疗炎症性疾病的策略。
Adv Immunol. 2020;145:55-93. doi: 10.1016/bs.ai.2019.11.003. Epub 2019 Dec 9.
引用本文的文献
1
A comprehensive analysis of the relationship between inflammasomes and autophagy in human tumors: Recent developments.人类肿瘤中炎性小体与自噬关系的综合分析：最新进展
J Cell Commun Signal. 2025 Jul 16;19(3):e70035. doi: 10.1002/ccs3.70035. eCollection 2025 Sep.
2
Targeting inflammasomes as a therapeutic potential for HIV/AIDS.将炎性小体作为治疗HIV/AIDS的潜在靶点。
Cell Mol Life Sci. 2025 Apr 17;82(1):162. doi: 10.1007/s00018-025-05685-x.
3
Flowers and Leaves of and Phytochemical Characterization, Anti-Inflammatory, Antioxidant, and Anti-Proliferative Activities Evaluation.[植物名称]的花和叶及其植物化学特征、抗炎、抗氧化和抗增殖活性评估。（你提供的原文中植物名称部分缺失）
Plants (Basel). 2025 Mar 26;14(7):1029. doi: 10.3390/plants14071029.
4
Phytochemical Composition Antioxidant and Anti-Inflammatory Activity of and .[具体植物名称1]和[具体植物名称2]的植物化学成分、抗氧化及抗炎活性
Antioxidants (Basel). 2024 Aug 20;13(8):1016. doi: 10.3390/antiox13081016.
5
The Neglected Sibling: NLRP2 Inflammasome in the Nervous System.被忽视的手足：神经系统中的 NLRP2 炎性小体。
Aging Dis. 2024 May 7;15(3):1006-1028. doi: 10.14336/AD.2023.0926-1.
本文引用的文献
1
Promise of the NLRP3 Inflammasome Inhibitors in In Vivo Disease Models.NLRP3 炎性小体抑制剂在体内疾病模型中的应用前景。
Molecules. 2021 Aug 18;26(16):4996. doi: 10.3390/molecules26164996.
2
Chemical Modulation of the 1-(Piperidin-4-yl)-1,3-dihydro-2-benzo[d]imidazole-2-one Scaffold as a Novel NLRP3 Inhibitor.作为新型NLRP3抑制剂的1-(哌啶-4-基)-1,3-二氢-2-苯并[d]咪唑-2-酮支架的化学修饰
Molecules. 2021 Jun 29;26(13):3975. doi: 10.3390/molecules26133975.
3
Preservation of Contractile Reserve and Diastolic Function by Inhibiting the NLRP3 Inflammasome with OLT1177 (Dapansutrile) in a Mouse Model of Severe Ischemic Cardiomyopathy Due to Non-Reperfused Anterior Wall Myocardial Infarction.在因未再灌注前壁心肌梗死导致的严重缺血性心肌病小鼠模型中，通过用OLT1177（达潘舒特rile）抑制NLRP3炎性小体来保留收缩储备和舒张功能。
Molecules. 2021 Jun 9;26(12):3534. doi: 10.3390/molecules26123534.
4
Phytochemical inhibitors of the NLRP3 inflammasome for the treatment of inflammatory diseases.天然产物 NLRP3 炎性小体抑制剂治疗炎症性疾病。
Pharmacol Res. 2021 Aug;170:105710. doi: 10.1016/j.phrs.2021.105710. Epub 2021 Jun 3.
5
Inflammasome Regulation: Therapeutic Potential for Inflammatory Bowel Disease.炎症小体调控：炎症性肠病的治疗潜力。
Molecules. 2021 Mar 19;26(6):1725. doi: 10.3390/molecules26061725.
6
Techniques to Study Inflammasome Activation and Inhibition by Small Molecules.研究小分子激活和抑制炎症小体的技术。
Molecules. 2021 Mar 18;26(6):1704. doi: 10.3390/molecules26061704.
7
NLRP3 Inflammasome Inhibitors in Cardiovascular Diseases.NLRP3 炎性小体抑制剂在心血管疾病中的应用。
Molecules. 2021 Feb 12;26(4):976. doi: 10.3390/molecules26040976.
8
Loganin Alleviates Gout Inflammation by Suppressing NLRP3 Inflammasome Activation and Mitochondrial Damage.毛兰素通过抑制 NLRP3 炎性小体激活和线粒体损伤缓解痛风性炎症。
Molecules. 2021 Feb 18;26(4):1071. doi: 10.3390/molecules26041071.
9
The Role of the Inflammasome in Neurodegenerative Diseases.炎性小体在神经退行性疾病中的作用。
Molecules. 2021 Feb 11;26(4):953. doi: 10.3390/molecules26040953.
10
Inflammasomes and the Maintenance of Hematopoietic Homeostasis: New Perspectives and Opportunities.炎性小体与造血稳态的维持：新视角和新机遇。
Molecules. 2021 Jan 9;26(2):309. doi: 10.3390/molecules26020309.
Zotero 插件